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Abstract The determination of high resolution three-dimen-
sional structures by X-ray crystallography or nuclear magnetic
resonance (NMR) is a time-consuming process. Here we describe
an approach to circumvent the cloning and expression of a
recombinant protein as well as screening for heavy atom
derivatives. The selenomethionine-modified chemokine macro-
phage inflammatory protein-II (MIP-II) from human herpes-
virus-8 has been produced by total chemical synthesis,
crystallized, and characterized by NMR. The protein has a
secondary structure typical of other chemokines and forms a
monomer in solution. These results indicate that total chemical
synthesis can be used to accelerate the determination of three-
dimensional structures of new proteins identified in genome
programs.
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1. Introduction
Genome sequencing programs are identifying proteins at a
pace that far exceeds the rate at which these proteins can be
characterized. The problem is particularly acute for high res-
olution structural studies, which normally require cloning,
overexpression, and puri¢cation to produce milligram quanti-
ties of proteins. Moreover, for X-ray crystallography, crystal-
lization and phase determination can be very time-consuming.
The replacement of methionine for selenomethionine allows
multiwavelength anomalous di¡raction (MAD) to be used
for solving the phase problem and can accelerate the determi-
nation of three-dimensional structures [1]. The incorporation
of selenomethionine into proteins typically requires growth of
cells in the presence of selenomethionine under conditions
where the methionine biosynthetic pathway is blocked. This
requirement once again necessitates the cloning, overexpres-
sion, and puri¢cation of the selenomethionine-modi¢ed pro-
teins.
Total chemical synthesis is an alternative means for produc-
ing proteins for structural studies [2]. Production of pure pro-
tein by this method can occur rapidly following identi¢cation
of a new protein sequence. This method of production has
been successfully applied to an increasing number of nuclear
magnetic resonance (NMR) studies. The determination of X-
ray structures has been limited to a smaller number of pro-
teins owing to the strict requirements for homogeneous sam-
ples required for crystallization. Recent advances in chemical
synthesis have now made possible the desired quality of sam-
ple for X-ray structural studies. Proteins or domains of up to
150 amino acids with appropriately spaced cysteine residues
are accessible by total chemical synthesis using thioester-medi-
ated native chemical ligation [2].
The chemokine superfamily is comprised of proteins rang-
ing in size between 7 and 15 kDa [3]. These proteins are
generally involved in recruiting cells of the immune system
to sites of infection or tissue injury. A number of chemokine
homologues and their receptors are encoded by viral genomes.
The human herpesvirus 8 (HHV-8) is the infectious agent
responsible for Kaposi sarcoma in patients with and without
HIV infection [4]. The HHV-8 genome encodes two genes
with sequence similarity to the human CC chemokine family.
HHV-8 macrophage in£ammatory proteins (MIP)-I (vMIP-I)
and MIP-II (vMIP-II) exhibit 37.9 and 41.1% amino acid
identity to MIP-1K, respectively [5]. The amino acid identity
between vMIP-I and vMIP-II is 48%, thus they are more
closely related to each other than to cellular chemokines, sug-
gesting that they have evolved by gene duplication within the
virus genome rather than by independent acquisition from the
host genome. Both vMIP-I and vMIP-II partially inhibit HIV-
1 infection of peripheral blood mononuclear cells. vMIP-II
was shown to block infection of HIV-1 on a CD4 positive
cell line expressing CCR3 and to a lesser extent on one ex-
pressing CCR5 [6]. vMIP-II has also been shown to inhibit
entry of HIV into T cells, mediated through CXCR4 [7]. Con-
sequently, this protein may serve as a lead for development of
broad-spectrum anti-HIV chemokine receptor antagonists.
In the present study, we demonstrate the accessibility of
selenomethionine ([SeMet])-vMIP-II to total chemical synthe-
sis and establish the utility of chemically synthesized seleno-
methionine-proteins for structural studies. The secondary
structure of [SeMet]-vMIP-II has been determined by two-
dimensional homonuclear and heteronuclear NMR spectro-
scopy. Furthermore, [SeMet]-vMIP-II has been crystallized
and the selenium sites determined by Patterson methods.
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2. Materials and methods
2.1. Total chemical synthesis of vMIP-II and [SeMet]-vMIP-II
vMIP-II was prepared by thioester-mediated native chemical liga-
tion of unprotected peptide segments [2]. The peptide segments were
synthesized by solid-phase methods either manually or on an Applied
Biosystems 430A Peptide Synthesizer. The ligation product, the poly-
peptide vMIP-II[(1^74)(-SH)4] was puri¢ed and folded in 2 M guani-
dine HCl, 100 mM Tris, pH 8, containing 8 mM cysteine and 1 mM
cystine. The amino acid sequence corresponds to residues 21^94 for
vMIP-II (GenBank accession number U75698). In the selenomethio-
nine-modi¢ed protein, Met-66 was replaced with a selenomethionine
residue to facilitate X-ray crystallographic studies. N-K-Fmoc-seleno-
L-methionine was prepared from commercially available seleno-L-me-
thionine (Sigma) and incorporated quantitatively into the peptide
chain preactivated as the 1-hydroxy-7-azobenzotriazole ester. The re-
sulting native and selenomethionine proteins were puri¢ed by re-
versed-phase HPLC and characterized by electrospray ionization
mass spectrometry (Fig. 1). The observed mass for the native and
[SeMet]-vMIP-II was 8400.4 and 8445.8 Da, respectively. These com-
pare favorably with the calculated mass (average isotope composition)
of 8397.9 and 8444.8 Da for 2 disul¢des in native and [SeMet]-vMIP-
II, respectively.
2.2. Crystallography
Lyophilized protein was dissolved in water at a concentration of 10
mg/ml. The vapor di¡usion method was used to identify crystalliza-
tion conditions. Crystals were ¢rst observed from 20% polyethylene
glycol 4000, 20% isopropanol, and 0.1 M citrate, pH 5.6. Crystals
grow in 2^3 days from optimized conditions. Crystals were equili-
brated in cryoprotectant consisting of mother liquor with 15% glyc-
erol. Di¡raction data to 2.8 Aî were collected from crystals frozen in a
stream of N2 at 3160‡C and measured with a RAXIS-IIC image plate
detector (Rigaku, Tokyo) using a Rigaku RU200 rotating anode X-
ray generator (operating at 50 mA and 100 kV) equipped with a Yale
double mirror system. X-ray data were processed with DENZO and
SCALEPACK [8]. The merging R-factors were 0.072 and 0.076 for
the native and [SeMet]-vMIP-II, respectively.
2.3. NMR spectroscopy
NMR samples were prepared by dissolving the lyophilized protein
in 90% H2O/10% D2O or D2O containing 50 mM phosphate and 0.1
mM NaN3. The pH was adjusted to pH 3.25 by adding microliter
increments of DCl or NaOD to a 0.6-ml sample. The ¢nal protein
concentration of [SeMet]-vMIP-II used for the detailed NMR analysis
was 2 mM. Preparation of the MIP-2 sample has been previously
described [29].
All NMR experiments were carried out on a Varian UNITY Plus
600-MHz spectrometer. The majority of NMR spectra were recorded
at a temperature of 308 K; some experiments were also recorded at
303 K and 313 K to resolve ambiguities. Clean total correlation spec-
troscopy (TOCSY) [9^11] experiments were carried out with mixing
times of 14, 30, 65, 80 and 100 ms. Nuclear Overhauser e¡ect spec-
troscopy (NOESY) [12,13] experiments were carried out with mixing
times of 50, 100, 150 and 200 ms. A rotating frame Overhauser e¡ect
spectroscopy (ROESY) [14] experiment was carried out with a mixing
time of 35 ms. A double quantum ¢ltered correlation spectroscopy
(DQF-COSY) experiment [15] was also performed. All spectra were
recorded in the phase-sensitive mode according to the method of
States et al. [16], with spectral widths of 8.5 kHz in both dimensions.
The water resonance in TOCSY and NOESY spectra was suppressed
by using the WET solvent suppression technique [17]. Twenty ms
selective pulses with a SEDUCE [18] pro¢le were employed in these
experiments. In other experiments, low power pre-irradiation of the
water resonance was used for solvent suppression.
The spectra were processed and analyzed using Felix 95 (Molecular
Simulations, San Diego, CA, USA). Prior to Fourier transformation
in t2, the NOESY and TOCSY data were multiplied by a weak Lo-
rentzian to Gaussian window function and zero-¢lled to yield ¢nal
spectra of 2 KU2 K points. DQF-COSY data were processed using
an exponential weighting in t2 and a sine-bell function in t1 and zero-
¢lled to 8 KU1 K points. Additional suppression of the water signal
was achieved by convolution of the time-domain data.
A 2D 1H-15N heteronuclear single quantum coherence (HSQC) ex-
periment [19] was acquired at natural abundance. GARP-1 was used
to decouple 15N during the acquisition period. The 1H and 15N car-
riers were placed at the water frequency and 119.0 ppm, respectively,
with spectral width of 8.5 kHz (1H) and 6 kHz (15N). The acquired
data consisted of 64 complex data points in t1 (15N) and 2048 complex
data points in t2 (1H). Zero-¢lling and linear prediction were em-
ployed to yield a ¢nal spectrum of 2048 (15N)U2048 (1H) points.
Slow amide proton exchange with solvent was measured at 308 K
by repeated acquisition of TOCSY spectra, acquired 0.5 h following
dissolution of the lyophilized protein sample in D2O. The total ac-
quisition time for a TOCSY spectrum was approximately 2 h. Qual-
itative hydrogen exchange rates were derived by comparison of amide
proton cross-peak volumes as a function of acquisition time.
The quaternary structure (i.e. monomer vs. dimer) of vMIP-II was
investigated by employing pulsed ¢eld gradient NMR self-di¡usion
measurements as described by Altieri et al. [20]. The water-suppressed
LED pulse sequence was used for these measurements. The value of
the coe⁄cient of self-di¡usion, Ds, was obtained by ¢tting the signal
attenuation as a function of gradient strength to Eq. 1:
A2V  A0exp3QNG2v3N=3Ds 1
where Q= 1H gyromagnetic ratio, N=PFG duration (s), G = gradient
strength (G/cm), and v= time between PFG pulses (s). Gradients
were calibrated using a spin-echo experiment.
3. Results and discussion
3.1. Crystallization
Crystals of vMIP-II have symmetry of space group P1 with
cell constants of a = 47.00 Aî , b = 45.64 Aî , c = 45.48 Aî ,
K= 101.43, L= 115.04, and Q= 110.86. The presence of a metal
ion such as Ni2 results in a space group with C2 symmetry
and dimensions a = 71.58 Aî , b = 58.62 Aî , c = 49.73 Aî ,
L= 131.85, with two molecules in the asymmetric unit. At-
tempts to solve the structure of either crystal form by molec-
ular replacement using various modi¢cations of MIP-1L, regu-
lated upon activation, normal T-cell expressed and
presumably secreted (RANTES), and monocyte chemoattrac-
tant protein (MCP)-1 as probes were unsuccessful. It is there-
fore likely that vMIP-II displays signi¢cant structural di¡er-
ences from other L-chemokines. Data collected from both
native and [SeMet]-vMIP-II have been used to calculate a
di¡erence Patterson map (Fig. 2). The positions of the two
selenium sites (one per monomer in the asymmetric unit) were
solved and re¢ned with the PHASES suite of programs (W.
Furey, University of Pittsburgh). The structure will now be
solved by multiwavelength anomalous di¡raction using the
[SeMet]-MIP-II crystals from data collected at a synchrotron
radiation source.
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Fig. 1. Characterization of puri¢ed [SeMet]vMIP-II. Main panel:
Analytical reversed-phase HPLC. Conditions: 5^65% acetonitrile
and 0.1% TFA in water over 30 min. Inset: Hypermass reconstruc-
tion of the ESI-MS spectrum observed mass 8445.8 Da; calculated
mass (average isotope composition) 8444.8 Da.
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3.2. NMR assignments
The sequential assignment of the residues in the 1H-NMR
spectrum was achieved by ¢rst identifying spin systems using
TOCSY spectra acquired with di¡erent mixing times and
DQF-COSY spectra. This procedure was followed by assign-
ing identi¢ed spin systems to particular residues in the protein
by the observation of sequential HN-HN, CKH-HN, and
CLH-HN NOEs [30]. Ambiguities arising from degenerate
chemical shifts were resolved by recording spectra at di¡erent
temperatures ranging from 303 to 313 K. The side-chain NH
resonances were not fully resolved in the 1H spectra but could
be resolved in a 2D 15N-1H HSQC spectrum (Fig. 3) and
linked with CLH or CQH resonances by NOEs in the NOESY
spectra. 15N and 1H chemical shifts are listed in Table 1.
3.3. Secondary structure
The secondary structure of vMIP-II was determined from a
qualitative analysis of the sequential, medium-range and some
long-range backbone NOE intensities, backbone scalar cou-
pling constants, amide proton exchange rate and chemical
shift analysis of CKH protons. vMIP-II contains a three-
stranded anti-parallel L-sheet, characterized by stretches of
strong sequential (dKN(i,i+1)) NOE connectivities, long-range
backbone NOE connectivities (dNN(i,j), dKN(i,j) and dKK(i,j))
(Fig. 4), reduced amide proton exchange rates and the CKH
chemical shift index of Wishart et al. [21] (Fig. 5). The ar-
rangement of the three L-strands into an anti-parallel L-sheet
is that of a Greek key: strand 2 (residues 43^46) is hydrogen
bonded to strands 1 (residues 30^33) and 3 (residues 52^55).
In addition, a C-terminal K-helix extending from 60 to 68 is
well-de¢ned, as characterized by the observed grouping of
dNN(i,i+1), dNN(i,i+2), dKN(i,i+3), and dKL(i,i+3) NOE connec-
tivities. Determination of the tertiary structure from NOE
distance constraints is now underway.
3.4. Quaternary structure
Dimerization is a characteristic feature of most chemokines
[22]. For most members of the CXC chemokine family (MIP-
2, MGSA, interleukin-8 (IL-8), NAP-2 and PF-4), the two
monomers associate to form an extended six-stranded L-sheet
with most of the subunit-subunit interactions formed between
the ¢rst L-strand of each monomer. (The tetramers of NAP-2
and PF-4 are formed by back-to-back association of the ex-
tended L-sheets of the two dimers.) The dimer interface of the
FEBS 21269 14-12-98
Fig. 3. 1H-15N-HSQC spectrum recorded at 600 MHz. The assign-
ments obtained in this study are indicated. The side-chain amide
resonances of individual Gln residues are connected by horizontal
lines.
Fig. 4. Regions of the NOESY (150 ms) spectrum of vMIP-II re-
corded at 600 MHz. The assignments obtained in this study are in-
dicated. A: Amide-amide region. B: HK-HK region.
Fig. 2. Di¡erence Patterson map for the [SeMet]-vMIP-II. The posi-
tions of the two selenium sites in the Patterson map are u = 0.32,
v = 0.0, w = 0.48 and u = 0.49, v = 0.0, w = 0.24, and re¢ne to x = 0.17,
y = 0.10, z = 0.24 and x = 0.24, y = 0.00, z = 0.13 as determined by the
PHASES package.
W. Shao et al./FEBS Letters 441 (1998) 77^82 79
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Table 1
Chemical shifts of vMIP-II in H2O solution at 308 K and pH 3.12
Residue 15N HN HK HL Others
Gly1 8.35 3.76, 4.13
Asp2 126.95 8.68 4.83 2.80, 2.87
Thr3 8.21 4.30 4.20 CQH3 1.17
Leu4 128.40 8.22 4.31 1.55, 1.64 HQ ^; CNH3 0.80, 0.84
Gly5 113.31 8.25 3.90, 3.90
Ala6 127.39 8.06 4.28 1.30
Ser7 118.08 8.17 4.36 3.80, 3.80
Trp8 125.99 7.86 4.56 3.17, 3.17 HN1 7.17; HO1 10.01; Hj2 7.38; HR2 7.14; HO3 7.51; Hj3 7.06; NO1 133.12
His9 124.30 7.92 4.47 2.89, 3.05 HN2 7.06; HO1 8.54
Arg10 126.95 8.04 4.23 1.70, 1.58 HQ 1.41, 1.53; HN 3.07; HO 7.13
Pro11 4.41 2.20 HQ 1.92, 1.96; HN 3.56, 3.69
Asp12 124.11 8.42 4.68 2.75, 2.80
Lys13 125.22 8.02 4.46 1.80, 1.91 HQ 1.44; HN 1.71; HO 2.97
Cys14 118.95 8.20 5.05 3.46, 2.66
Cys15 8.85 4.68 2.64, 2.64
Leu16 127.53 8.76 4.27 1.58 HQ 1.58; CNH3 0.83, 0.90
Gly17 110.51 7.34 3.70, 3.70
Tyr18 120.59 8.13 4.85 3.13, 2.70 HN 6.85; HO 6.69
Gln19 127.38 8.84 4.33 2.07, 2.46 HQ 2.63; NOH 6.89, 8.29; NO 116.59
Lys20 132.11 8.71 4.48 1.94, 1.94 HQ 1.52, 1.64; HN 1.78; HO 3.09
Arg21 124.11 7.69 4.42 1.56 HQ 1.56; HN 3.12; NOH 7.13
Pro22 1.84 1.06, 1.10 HQ 0.59, 1.58; HN 3.12, 3.46
Leu23 5.38 4.50 1.11, 1.37 HQ 1.60; CNH3 0.82, 0.86
Pro24 4.40 1.90, 2.27 HQ 1.98, 2.03; HN 3.44, 3.74
Gln25 127.24 8.61 3.56 1.95, 2.10 HQ 2.26, 2.30; NO 113.75
Val26 115.84 7.73 4.09 2.27 CQH3 0.96, 1.01
Leu27 122.37 7.37 4.42 1.67, 1.74 HQ 1.74; CNH3 0.91, 0.94
Leu28 123.72 8.03 4.82 1.41, 2.06 HQ 1.78; CNH3 0.41, 0.65
Ser29 116.49 9.16 4.78 3.58, 3.72
Ser30 114.61 7.87 5.14 3.87, 4.06
Trp31 120.64 8.37 5.89 2.93, 2.59 HN1 6.83; HO1 9.60; Hj2 7.43; HR2 7.07; HO3 6.83; Hj3 6.70; NO1 134.71
Tyr32 117.65 8.90 4.58 2.89, 3.03 HN 7.01; HO 6.58
Pro33 5.10 2.42, 2.27 HQ 2.19; HN 3.50, 3.66
Thr34 112.58 7.77 4.50 4.90 CQH3 1.22
Ser35 118.61 8.69 4.36 3.96, 4.12
Gln36 130.18 9.01 4.25 2.10, 2.19 HQ 2.45, 2.49; NO 113.75
Leu37 121.89 8.19 4.26 1.58 HQ 1.58; CNH3 0.83, 0.89
Cys38 121.84 7.35 4.60 3.43, 2.73
Ser39 122.08 8.61 4.15 3.91
Lys40 123.92 8.05 4.74 1.68, 1.68 HQ 1.29, 1.32; HN 1.44; HO 2.82; HNR 7.63
Pro41 4.58 1.88, 2.26 HQ 2.04; HN 3.60, 3.74
Gly42 113.12 8.34 4.16, 4.59
Val43 123.29 8.68 4.64 1.62 CQH3 0.34, 0.45
Ile44 127.82 8.83 4.55 1.74 HQ 1.52, 1.89; CQH3 0.76; CNH3 0.62
Phe45 126.47 9.11 5.23 2.98, 2.77 HN 7.08; HO 6.68; Hj 6.83
Leu46 126.95 8.94 5.38 1.68, 1.72 HQ 1.70; CNH3 0.60, 0.92
Thr47 118.52 9.35 5.00 4.88 CQH3 1.21; OQ1H 6.21
Lys48 125.22 8.74 4.14 1.92, 1.72 HQ 1.23, 1.33; HN 1.72; HO 3.00; HNR 7.45
Arg49 118.57 7.49 4.50 2.15, 1.64 HQ 1.75; HN 3.22; HNO 7.18
Gly50 111.96 7.98 3.66, 4.23
Arg51 123.48 7.51 4.54 1.73, 1.89 HQ 1.50; HN 3.14; HNO 7.19
Gln52 124.59 8.49 5.25 2.03, 1.95 HQ 2.21, 2.47; NO 115.72
Val53 127.82 9.40 4.44 2.12 CQH3 0.87, 1.05
Cys54 129.94 8.85 5.32 3.29, 3.42
Ala55 129.85 9.70 4.87 1.27
Asp56 123.48 8.23 3.93 2.38, 1.37
Lys57 127.68 7.69 3.69 1.40, 1.68 HQ 1.12; HN 1.47; HO 2.82; HNR 7.39
Ser58 116.83 8.20 4.15 3.84, 3.74
Lys59 124.83 7.23 4.31 1.48 HQ 1.24; HN 1.73; HO 2.94, 3.10
Asp60 128.16 9.07 4.15 2.84, 2.89
Trp61 121.12 8.47 4.30 3.23, 3.48 HN1 7.67; HO1 10.57; Hj2 7.26; HR2 6.70; HO3 7.32; Hj3 6.50; NO1 134.52
Val62 128.26 5.99 2.95 1.73 CQH3 30.79, 0.38
Lys63 123.34 7.56 4.03 1.73, 1.42 HQ 1.24; HN 1.56; HO 2.82
Lys64 120.88 7.72 3.99 1.80 HQ 1.41; HN 1.64; HO 2.96
Leu65 122.95 7.08 4.06 1.17, 2.03 HQ 2.03; CNH3 0.65, 0.84
Met66 120.69 7.93 2.92 1.80 HQ 2.00
Gln67 117.17 7.10 4.27 2.22 HQ 2.42, 2.55; NO 114.85
Gln68 120.16 7.50 4.37 2.23, 1.99 HQ 2.39, 2.52; NO 114.66
W. Shao et al./FEBS Letters 441 (1998) 77^8280
CC chemokines MIP-1L, RANTES, and MCP-1 is formed by
a completely di¡erent set of residues located predominantly at
the extended loop of the amino terminus and gives rise to an
elongated, cylindrical molecule.
The di¡erent quaternary structure of CXC and CC chemo-
kines o¡ered an attractive rationalization for the receptor
binding speci¢cities of chemokines. Prior to the identi¢cation
of vMIP-II, CXC chemokines could compete only with each
other for binding to CXC chemokine receptors, while CC
chemokines could only compete for binding to CC chemokine
receptors [3]. This absolute speci¢city for binding and activa-
tion of chemokine receptors could be explained by invoking
the recognition of the quaternary structures of chemokines
by chemokine receptors. However, the physiological role of
chemokine oligomerization and its relationship to receptor
binding and activation is still unclear.
Studies of IL-8 have shown that IL-8 dimerizes in solution
with a Kdd (dimer dissociation constant) of about 10^20 WM
under conditions approaching physiological [23,24]. Because
IL-8 binds its known receptors with nanomolar a⁄nities
(KdV1^2 nM for neutrophil receptors), and neutrophil chem-
otaxis and degranulation are induced over the same range, it
was suggested that the monomeric form was the active species.
A monomeric variant of IL-8 was produced by synthetic
means [25] that e¡ectively disrupted IL-8 dimer formation
by altering the backbone hydrogen bond network at the dimer
interface by incorporating N-methyl-Leu (instead of leucine)
at position 25. This synthetic mutant was active in binding
and activating neutrophils in vitro, providing evidence that
the monomeric form of IL-8 is active.
More recent studies, however, provide evidence that dimer-
ization may be important for biological activity. For example,
it has been shown that IL-8 dimer formation may occur at
concentrations that are considerably lower than 10 WM [26].
Studies with single-chain dimers of IL-8 have shown that dis-
sociation of the dimeric species is not required for biological
activity [27]. It is important to note that the oligomerization
state of chemokines in vivo is not known. The presence of
proteoglycans on the cell surface and in the extracellular ma-
trix may in£uence the oligomerization state of chemokines
and regulate their biological activity [28].
Our NMR data have allowed us to establish the oligomer
state of the vMIP-II protein in solution. The absence of slowly
exchanging amide protons for the N-terminal residues of
vMIP-II suggests that the N-terminal region is not involved
in inter-subunit interactions. In addition, no NOE contacts
analogous to those that are found in chemokine dimers of
either CC or CXC class were detected. The monomeric struc-
ture of vMIP-II was con¢rmed by employing pulsed ¢eld gra-
dient NMR self-di¡usion measurements using the water-sup-
pressed LED pulse sequence [20]. The ¢ts of the data to Eq. 1
(Section 2) are shown in Fig. 6. Using this method, the ex-
perimental measurements of the coe⁄cient of self-di¡usion,
Ds, were 1.50 þ 0.06U1036 cm2/s and 1.09 þ 0.05U1036 cm2/
s for vMIP-II and MIP-2, respectively. The Ds value of vMIP-
II is in good agreement with the Ds value of 1.49U1036 cm2/s
previously found for ubiquitin, a known monomeric protein
that is similar in size (76 amino acid residues, 8.7 kDa) to
vMIP-II [20]. The di¡usion coe⁄cient for vMIP-II at pH
7.0 is 1.52 þ 0.04U1036 cm2/s (data not shown), which is in
good agreement with the data measured at pH 3.2. On the
other hand, the Ds value of MIP-2, which has been recently
shown to be a dimer in solution [29], is similar to the Ds value
of 1.08U1036 cm2/s previously found for MCP-1, another
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Table 1 (Continued).
Chemical shifts of vMIP-II in H2O solution at 308 K and pH 3.12
Residue 15N HN HK HL Others
Leu69 124.59 7.95 4.93 2.13, 1.54 HQ 1.80; CNH3 0.22, 0.97
Pro70 4.62 1.95, 2.28 HQ 2.16; HN 3.88, 4.01
Val71 122.52 7.69 3.95 1.48 CQH3 0.58, 0.25
Thr72 127.77 8.58 3.98 3.67 CQH3 1.05
Ala73 132.11 8.11 4.22 1.27
Arg74 127.34 7.82 4.02 1.52, 1.68 HQ 1.38; HN 2.95; HNO 7.01
Fig. 5. Summary of the sequential NOE connectivities, backbone amide proton exchange rates, and chemical shift index of CKH protons for
vMIP-II. The relative strengths of the NOEs are indicated by the thickness of the lines. Slowly exchanging amide protons are indicated by a
solid circle. More rapidly exchanging amide protons are indicated by an open circle. The chemical shift index of each CKH is indicated by ‘3’,
‘0’, or ‘+’, corresponding to the indices 31, 0, +1, respectively, described by Wishart et al. [21].
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dimeric chemokine [20]. We therefore conclude that vMIP-II
is a monomer in solution at NMR concentrations.
In summary, we have produced [SeMet]-vMIP-II by total
chemical synthesis. The crystallization of this protein and de-
termination of its selenium sites by Patterson methods indi-
cate that chemical synthesis is a viable method for producing
proteins for crystallographic studies. Solution studies of [Se-
Met]-vMIP-II indicate that the protein is a monomer in sol-
ution and has an K/L structure similar to other chemokines.
These studies demonstrate that total chemical synthesis of
proteins can be used to bypass the requirement for cloning,
expression, and puri¢cation, and can accelerate functional and
structural studies of newly identi¢ed small, soluble proteins or
domains.
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Fig. 6. Determination of the coe⁄cients of self-di¡usion, Ds, for
MIP-2 and vMIP-II. Circles: MIP-2. Triangles: vMIP-II.
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